LIA
AMED

LS Investment Advisors’s Amedisys AMED Stock Holding History

LS Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,858
Closed -$492K – 191
2021
Q1 		$492K Sell
1,858
-437
-19% -$123K 0.03% 388
2020
Q4 		$673K Buy
2,295
+199
+9% +$51K 0.04% 343
2020
Q3 		$496K Sell
2,096
-92
-4% -$20.9K 0.03% 388
2020
Q2 		$434K Buy
2,188
+29
+1% +$5.41K 0.03% 421
2020
Q1 		$396K Hold
2,159
– – 0.03% 388
2019
Q4 		$360K Sell
2,159
-845
-28% -$126K 0.02% 599
2019
Q3 		$394K Buy
3,004
+90
+3% +$11.7K 0.02% 527
2019
Q2 		$354K Sell
2,914
-99
-3% -$11.7K 0.02% 571
2019
Q1 		$371K Buy
3,013
+835
+38% +$105K 0.02% 558
2018
Q4 		$255K Sell
2,178
-719
-25% -$84.7K 0.02% 653
2018
Q3 		$362K Sell
2,897
-552
-16% -$61K 0.02% 619
2018
Q2 		$295K Sell
3,449
-119
-3% -$8.74K 0.02% 702
2018
Q1 		$215K Buy
3,568
+4
+0.1% +$228 0.01% 809
2017
Q4 		$188K Buy
3,564
+2,494
+233% +$131K 0.01% 934
2017
Q3 		$60K Hold
1,070
– – ﹤0.01% 1288
2017
Q2 		$67K Hold
1,070
– – ﹤0.01% 1261
2017
Q1 		$55K Sell
1,070
-100
-9% -$4.77K ﹤0.01% 1300
2016
Q4 		$50K Hold
1,170
– – ﹤0.01% 1253
2016
Q3 		$56K Hold
1,170
– – ﹤0.01% 1180
2016
Q2 		$59K Buy
1,170
+44
+4% +$2.22K ﹤0.01% 1147
2016
Q1 		$54K Buy
1,126
+84
+8% +$3.24K ﹤0.01% 1145
2015
Q4 		$41K Hold
1,042
– – ﹤0.01% 1225
2015
Q3 		$40K Sell
1,042
-147
-12% -$6.2K ﹤0.01% 1228
2015
Q2 		$47K Buy
+1,189
New +$37K ﹤0.01% 1201

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

LS Investment Advisors's AMED Position: Q2 2021 in Review

LS Investment Advisors sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,858 shares — an estimated $492K sold.

LS Investment Advisors first reported a position in AMED in Q2 2015 and held it in 24 quarters. The position peaked at $673K in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • LS Investment Advisors reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 1,858 Amedisys shares in Q2 2021, an estimated $492K.
  • LS Investment Advisors first reported a position in Amedisys in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's Amedisys position peaked at $673K in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.